Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy followed by carbon-ion radiotherapy: a case report

[1] Konstantinidis IT(2013)Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? Ann Surg 257 731-736

[2] Warshaw AL(2018)Long-term outcomes after pancreatectomy for pancreatic ductal adenocarcinoma in elderly patients: special reference to postoperative adjuvant chemotherapy World J Surg 42 2617-2626

[3] Allen JN(2019)Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues Surg Today 49 894-906

[4] Watanabe Y(2018)Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer J Hepatobiliary Pancreat Sci 25 261-268

[5] Shinkawa T(2013)Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable responses to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery J Hepatobiliary Pancreat Sci 20 590-600

[6] Endo S(2020)Role of conversion surgery for unresectable pancreatic cancer after long-term chemotherapy World J Surg 44 2752-2760

[7] Yoshitomi H(2018)A single institutional experience of combined carbon-ion radiotherapy and chemotherapy for unresectable locally advanced pancreatic cancer Radiother Oncor 129 333-339

[8] Takano S(2018)Multi-institutional study of carbon-ion radiotherapy for locally advanced pancreatic cancer: Japan carbon-ion radiation oncology study group (J-CROS) study 1403 pancreas Int J Radiat Oncol Biol Phys 101 1212-1221

[9] Furukawa K(2016)Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without Erlotinib: The LAP07 randomized clinical trial JAMA 315 1844-1853

[10] Furuse J(2016)Preoperative gemcitabine-based chemoradiation therapy for borderline resectable pancreatic cancer: impact of venous and arterial involvement status on surgical outcome and pattern of recurrence Ann Surg 264 1091-1097

[1] Konstantinidis IT(2013)Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? Ann Surg 257 731-736

[2] Warshaw AL(2018)Long-term outcomes after pancreatectomy for pancreatic ductal adenocarcinoma in elderly patients: special reference to postoperative adjuvant chemotherapy World J Surg 42 2617-2626

[3] Allen JN(2019)Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues Surg Today 49 894-906

[4] Watanabe Y(2018)Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer J Hepatobiliary Pancreat Sci 25 261-268

[5] Shinkawa T(2013)Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable responses to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery J Hepatobiliary Pancreat Sci 20 590-600

[6] Endo S(2020)Role of conversion surgery for unresectable pancreatic cancer after long-term chemotherapy World J Surg 44 2752-2760

[7] Yoshitomi H(2018)A single institutional experience of combined carbon-ion radiotherapy and chemotherapy for unresectable locally advanced pancreatic cancer Radiother Oncor 129 333-339

[8] Takano S(2018)Multi-institutional study of carbon-ion radiotherapy for locally advanced pancreatic cancer: Japan carbon-ion radiation oncology study group (J-CROS) study 1403 pancreas Int J Radiat Oncol Biol Phys 101 1212-1221

[9] Furukawa K(2016)Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without Erlotinib: The LAP07 randomized clinical trial JAMA 315 1844-1853

[10] Furuse J(2016)Preoperative gemcitabine-based chemoradiation therapy for borderline resectable pancreatic cancer: impact of venous and arterial involvement status on surgical outcome and pattern of recurrence Ann Surg 264 1091-1097